Loss of Control Eating

0
Pipeline Programs
2
Companies
1
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

1 companies ranked by most advanced pipeline stage

NeuroPace
NeuroPaceMOUNTAIN VIEW, CA
1 program
responsive neurostimulationN/A1 trial
Active Trials
NCT03868670Active Not RecruitingEst. Jan 2028

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
2027
2028
NeuroPaceresponsive neurostimulation

Clinical Trials (1)

NCT03868670NeuroPaceresponsive neurostimulation

Responsive Neurostimulation For Loss Of Control Eating

Start: Apr 2019Est. completion: Jan 2028
N/AActive Not Recruiting

Phase Legend

Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available

Key Insights

2 companies competing in this space